Integrated behavioral health services may help address patient needs with opioid use disorder, the authors say
Few offer other evidence-based treatments
Despite this, one in five report using cigarettes daily
Extended-release injection available in lower doses to be administered in health care settings by health care providers
Methadone dispensing up after 2020 without displacing use of buprenorphine
More White than Black and Hispanic patients receive buprenorphine, naloxone, benzodiazepines in 180 days after index event
Persons receiving medication for opioid use disorder more likely to be older, White and to have public insurance
Review shows positive effects on cessation of substance use, aerobic capacity, depressive symptoms
Median monthly retention rate was 22.2 percent during January 2016 through April 2022
Conditioned open-label placebo had no impact on the 90-day methadone dose, but did improve sleep quality